BBH ETF

$203.57

Returns Overview

1 Month
+4.41%
3 Months
+9.64%
6 Months
+1.77%
YTD
+7.01%
1 Year
+33.20%
3 Years (annualized)
+9.81%
5 Years (annualized)
+0.62%
10 Years (annualized)
+7.56%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would BBH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+4.41%

3 Months Performance

+9.64%

6 Months Performance

+1.77%

1 Year Performance

+33.20%

Benchmark & Peers

Benchmark
MVIS US Listed Biotech 25 Index(^MVBBH)
This ETF (YTD)
+7.01%
Peer Avg (YTD)
+7.57%
vs Peers
-0.56%

BBH ETF Performance

BBH performance across multiple time periods: 1-month 4.41%, YTD 7.01%, 1-year 33.20%, 3-year 9.81%, 5-year 0.62%, 10-year 7.56%.

BBH returns trail the peer average of 7.57% YTD. With an expense ratio of 0.35%, investors should weigh costs against performance when evaluating this ETF.

BBH performance comparison shows side-by-side returns with another fund. BBH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+4.41%Jun 24, 2026 to Jul 24, 2026
3 Months+9.64%Apr 24, 2026 to Jul 24, 2026
6 Months+1.77%Jan 26, 2026 to Jul 24, 2026

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized